Psyence Biomedical Ltd
NASDAQ:PBM
Cash Flow Statement
Cash Flow Statement
Psyence Biomedical Ltd
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
13
|
14
|
8
|
5
|
3
|
|
| Other Non-Cash Items |
(14)
|
(15)
|
(8)
|
(7)
|
(4)
|
|
| Change in Working Capital |
(0)
|
(0)
|
(0)
|
1
|
0
|
|
| Cash from Operating Activities |
(1)
N/A
|
(1)
-8%
|
(1)
+59%
|
(1)
-63%
|
(1)
-15%
|
|
| Investing Cash Flow | ||||||
| Other Items |
0
|
0
|
0
|
243
|
243
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
243
N/A
|
243
0%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
258
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
1
|
1
|
|
| Other |
(1)
|
(1)
|
0
|
(243)
|
(243)
|
|
| Cash from Financing Activities |
256
N/A
|
256
N/A
|
0
N/A
|
(242)
N/A
|
(242)
+0%
|
|
| Change in Cash | ||||||
| Net Change in Cash |
0
N/A
|
0
-29%
|
(1)
N/A
|
(0)
+19%
|
(0)
+31%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(1)
N/A
|
(1)
-8%
|
(1)
+59%
|
(1)
-63%
|
(1)
-15%
|
|